Associate Director
Apnimed
Associate Director
Apnimed
Clinical-stage biotech developing oral OSA therapies
Apnimed · Cambridge, United States (Remote) · Full-time · Posted 2026-11-02
Salary: USD 160,000–180,000
Workplace: remote
Department: CMC
Apnimed is a rapidly growing pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea (OSA) could benefit from treatment with a safe and effective oral medication dosed once daily at bedtime. Our lead development program, AD109, targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Apnimed is committed to innovation, as well as state-of-the-art advancements in sleep medicine, which is leading to the development of a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.
Recognized by the Boston Business Journal as one of the Best Places to Work in both 2024 and 2025, we are continuing to grow and build the foundational operations that enable our employees and our mission to thrive.
The Associate Director, Commercial Supply Chain reports to the Senior Director, Supply and Manufacturing and is responsible for overseeing and managing all aspects of commercial drug supply, including production planning at CMOs, commercial packaging and labeling execution, logistics, and inventory management. The successful candidate will also play a key role in integrating closely with our internal commercial forecasting organization and managing daily business relationships with all of our strategic supply business partners. This is an exciting opportunity to help drive Apnimed’s commercial success as part of a major paradigm shift in the treatment of sleep apnea from medical devices and surgery to a first in class pharmaceutical treatment.
The expected annual base salary range for this role is $160,000.00 to $180,000.00. Final compensation will depend on the selected candidate’s level, education and relevant experience.
Responsible for proper serialization coding, barcoding, and GTIN (for each SKU) globally, per current regulations and GS1 standards
Own and generate monthly commercial supply plans, and develop, coordinate, prioritize, and maintain the S&OP commercial strategy, working with Commercial Operations and Finance to translate demand plans and market analytics into actionable and robust supply plans
Powered by Workable
Apnimed develops oral therapies for obstructive sleep apnea (OSA), focusing on the neurological causes of the condition. Its lead candidate, AD109, is intended to be a disease-modifying oral treatment that targets the underlying biology of OSA rather than just alleviating symptoms. This approach sets it apart from most current options, which rely on devices or surgery rather than drugs. The company aims to bring an approved oral medication to patients and generate revenue through commercialization after regulatory approval.
Explore more opportunities at Apnimed